Form 4: Avid Bioservices CFO Daniel Hart Disposes of Shares, Options, and Units in Merger with Space Mergerco, Inc.

Daniel Hart, CFO of Avid Bioservices, Inc., disposed of common stock, stock options, restricted stock units, and performance stock units due to the merger with Space Mergerco, Inc., receiving cash payments as per the merger agreement.

Summary

• A Form 4 filing reveals that Daniel R. Hart, the Chief Financial Officer of Avid Bioservices, Inc. (CDMO), disposed of various securities due to the merger of Space Mergerco, Inc. with Avid Bioservices.
• The transaction occurred on February 5, 2025.
• Hart disposed of 112,735 shares of common stock, which were converted into the right to receive a cash payment of $12.50 per share.
• He also disposed of stock options, restricted stock units (RSUs), and performance stock units (PSUs), which were converted into cash payments based on the merger agreement terms.
• Vested options were converted into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option.
• Vested and unvested RSUs were converted into the right to receive a cash payment of $12.50 per share.
• Vested and unvested PSUs were converted into the right to receive a cash payment of $12.50 per share based on performance metrics.
• Following the transactions, Hart's direct ownership of common stock, stock options, and restricted/performance stock units is now zero.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it primarily reports the execution of a merger agreement and the resulting disposal of securities by a company officer. It's a factual disclosure with no inherent positive or negative implications for the company's future beyond the merger itself.

Future Outlook

The document does not contain any specific forward-looking statements beyond the completion of the merger.

Industry Context

This announcement reflects a merger and acquisition activity within the bioservices industry, where companies are often acquired for their assets, technology, or market position. The acquisition of Avid Bioservices by Space Finco, Inc. suggests a strategic move to consolidate or expand within the contract development and manufacturing organization (CDMO) sector.

Comparison to Industry Standards

• It's difficult to compare this specific transaction to industry standards without knowing the strategic rationale behind the acquisition.
• However, M&A activity in the CDMO space is common, with valuations typically based on multiples of revenue or EBITDA.
• Comparable companies in the CDMO sector include Catalent, Thermo Fisher Scientific, and Lonza, which have all been involved in significant acquisitions and mergers.
• The $12.50 per share cash payment would need to be assessed against Avid Bioservices' pre-merger valuation and financial performance to determine if it aligns with industry norms.

Stakeholder Impact

• Shareholders received $12.50 per share as part of the merger agreement.
• Employees' positions may be affected by the merger, depending on the acquirer's plans for the company.
• Customers and suppliers may experience changes in their relationships with the company as a result of the merger.

Key Dates

Keywords

Form 4, Avid Bioservices, Merger, Daniel Hart, CFO, CDMO, Space Mergerco, Stock Options, Restricted Stock Units, Performance Stock Units, Beneficial Ownership, Securities Exchange Act